Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by canadafanon May 02, 2023 5:59pm
295 Views
Post# 35426228

Re up 50% last week or so….nice trend

Re up 50% last week or so….nice trend

I agree ,westcoast. Nice uptick.
slow & steady, no major spikes. There was some chatter on another site, regarding shorting.
That could account for the mid day dip? More importantly the end of day recovery.
Yes, close to 50% upside since they announced the upcoming ASCO presentation.
It has been noted, being an oral presentation vs just an abstract poster, means something good in the wings.
There is no way, Onc would elevate a presentation of bad news.
since the ASCO updates are quite a few days away, what about the short term?
This Friday, they will be having Q1, conference call, 8:30 am.
They always preface that with an earlier N.R. 
Even minor updates after this run will sustain the run.
Looking at Onc investor presentation, they show timlines for CAR-t, as well as Bracelet updates, this quarter.
with  the Pancreatic data, soon after.
All said, they have a few irons in the fire.  FYI, assuming a similar climb,me could be very close to $3CDN, by this Friday.
ionically the first glimps we will get if the ASCO presentation, I believe is the 26th of this month?
That is a lot of 10% trading days!
I actually do hope a few try shorting. Will be fun to watch the other side when " good news" , moves the price uowards 50% in one day.
Some May recall the short squeeze Dec 2019.?
Was a blast. Price went from near $1, to just above $6....in 3 weeks.
I caution those who are new. Because of ONCs shareholder profiles the SP can swing wildly.
The recent 9%-10%/ day we have seen recently is certainly nice. However, very small potatoes.
As westcoast pointed out, the major markets down huge today. Yet Onc up!
Also, I have seen zero evidence of Oncy using the ATM.
Have a great healthy & safe week all.

 

 

<< Previous
Bullboard Posts
Next >>